In just less than 60 seconds, you can change the course of your health. In today's busy world, it’s easy to overlook something as simple, yet vital, as our health. Did you know that less than 60 seconds, is all it takes to check your risk for diabetes? Yes, this small timely action can have a life-changing impact. Less than 60 seconds is all that it takes for simple tasks in life: tying your shoelace, washing your hands, or putting on your jacket. Taking a minute to check your diabetes risk today, can prevent years of complications tomorrow. Early detection doesn’t just offer hope, it offers control. Don’t wait for symptoms - take action now. Because action you take today can impact your health tomorrow. Take control of your health. Take the test. #EarlyDetection #TakeTheTest #DiabetesAwareness Shreehas Tambe Mandar Ghatnekar Kedar Upadhye Rhonda Duffy Naveen Narayanan Matt Erick Anuj Goel Susheel Umesh Seema Shah Ahuja Stephanie Wasco Arlene Wolny Uwe Gudat Ankur Bhatnagar Kathleen Blanchard Akhilesh Nand Stephen Fecho, Jr Dwight Hanshew Ganesh Reddy D Dave Gibson Jozef Belcik Paul Harmon RPN, MBA, MSc. Wakim Andre Rinat Livne Marcelo Holanda Souhail Tebib Jay (Jihad) Bou Daher
Biocon Biologics
Biotechnology Research
Bengaluru, Karnataka 494,824 followers
Transforming Healthcare. Transforming Lives.
About us
Biocon Biologics Limited, a subsidiary of Biocon Limited, is a fully integrated global biosimilars organization. It is leveraging cutting-edge science, innovative tech platforms and advanced research & development capabilities to lower treatment costs while improving healthcare outcomes. It has a strong research pipeline of biosimilar molecules across diabetes, oncology, immunology, and other non-communicable diseases. Six molecules from Biocon Biologics’ portfolio have been taken from lab to market in developed markets like United States, EU, Australia, Canada and Japan. With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide. Follow-us on Twitter: @BioconBiologics
- Website
-
http://www.bioconbiologics.com
External link for Biocon Biologics
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Bengaluru, Karnataka
- Type
- Privately Held
- Founded
- 1978
Locations
-
Primary
Hosur Road
Bengaluru, Karnataka 560100, IN
-
16 GREAT QUEEN STREET
Employees at Biocon Biologics
Updates
-
More than 100 of our suppliers came together at Symposia '24, Biocon Biologics annual suppliers’ summit, to strengthen our relationship and reaffirm our collaborative mission. Organized by the Global Procurement Team, Symposia '24 was attended by senior leaders of the Company, who shared their experience, expectations and future aspirations vis-à-vis our key stakeholders. Our suppliers narrated their success stories and voiced their appreciation for our valued partnership.The summit had knowledge sharing & capacity building sessions on digital transformation and panel discussions on a range of topics, including ‘Resilience in Supply Chains due to Global Geopolitical Issues', 'Circular Economy and Bio-Pharma Supply Chains', and a Fireside Chat on ESG. Our Chief Operating Officer Rhonda Duffy, Chief Financial Officer Kedar Upadhye, Chief Development Officer Anuj Goel and Global Head of IT & Digital Transformation Mandar Ghatnekar also graced the event and addressed the suppliers.
-
-
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval for Biocon Biologics' biosimilar Ustekinumab. This follows the USFDA approval earlier this month. Biosimilar Ustekinumab is intended to treat adults and children with plaque psoriasis, and adults with psoriatic arthritis or Crohn’s disease. Clinical studies have confirmed its comparable pharmacokinetic, safety, efficacy, and immunogenicity profile to the originator product. This reflects our commitment to bring high-quality, affordable biosimilars to patients globally. Read More : https://bit.ly/CSP20241215
-
-
Integrity and ethical behaviour are among our Company's core values. To mark Anti-Corruption Day, Arun Kasat, Head - Global Corp Compliance & Commercial Compliance (EM), reaffirms our commitment to integrity as the cornerstone of sustainable business practices.
-
-
At Biocon Biologics, ethics and compliance are the guiding principles of our operations. Akhilesh Nand Head – GRC (Governance, Risk, Compliance) & Company Secretary, underlines that there can be no compromise on conducting our business in line with the highest ethical standards.
-
-
“We are humbled to be recognized for the eighth consecutive year as an Asia IP Elite company by IAM. This accolade reflects our unwavering commitment to innovation, IP excellence, and patient-centric solutions. It underscores Biocon Biologics’ position as a global leader in biosimilars and highlights the critical role of our robust IP strategy in enabling affordable access to high-quality therapies worldwide. Our dedicated team places intellectual property at the heart of our business, driving value creation and advancing healthcare solutions for millions of patients globally.” –Shreehas Tambe, CEO & Managing Director Biocon Biologics #AsiaIPElite #BioconBiologics #Innovation #IPExcellence #GlobalImpact #Biosimilars #PatientCentricity
-
-
Biocon Biologics Recognized as #AsiaIPElite for 2024 We are proud to announce that Biocon Biologics Limited has been recognized as an Asia IP Elite for the eighth consecutive year by IAM, the world’s leading Intellectual Property publication. This recognition honors organizations across Asia for their exceptional IP value creation and leadership in intellectual property management. In 2016, Biocon became the first and only Indian pharmaceutical company to feature on this esteemed list for its robust IP practices. Biocon Biologics is among the two pharmaceutical companies from India in the 93 companies featuring on the Asia IP Elite 2024 list. This achievement underscores our commitment to innovation, IP excellence, and advancing global healthcare. Read More : https://bit.ly/PR20241211 #ASIAIPELITE #IPEXCELLENCE #IAM #INTELLECTUALPROPERTY Shreehas Tambe Mandar Ghatnekar Kedar Upadhye Rhonda Duffy Naveen Narayanan Matt Erick Anuj Goel Susheel Umesh Seema Shah Ahuja Stephanie Wasco Arlene Wolny Uwe Gudat Ankur Bhatnagar Kathleen Blanchard Akhilesh Nand Stephen Fecho, Jr Dwight Hanshew Ganesh Reddy D Dave Gibson
-
-
As an institutional sponsor, Biocon Biologics would like to thank all the hospital teams who took part in the @Grand Prix for the best initiative in rheumatology with the Lettre du Rhumatologue. All the projects illustrate the day-to-day involvement of the multidisciplinary teams in supporting patients throughout their treatment. The three winners selected by the panel of experts are: 1st prize: Department of Rheumatology, CHU Lapeyronie, Montpellier & University of Montpellier & Inserm U1046, CNRS UMR 9214, University of Montpellier / Physiology and Experimental Medicine of the Heart and Muscles (PhyMedExp), Montpellier, France 2nd prize: Clinical Immunology and Osteoarticular Therapeutics Department/ Osteoarticular Pole Hôpital Lapeyronie, CHU de Montpellier 3rd prize: Department of Internal Medicine APHP Bichat Hospital This event gives us the opportunity to demonstrate Biocon Biologics' commitment to rheumatology and to supporting teams with innovative initiatives. #BioconBiologics #SFR #Rhumatology #Rheumatologists #EDIMARK #LaLettreduRhumatologue #GrandPrixInitiative #Event #Paris
-
Eight years & counting! Proud to have won the #2024BestCompaniesforWomen in India award at the #BestoftheBest Conference by Avtar The Power of Diversity, once again! This award recognizes our engagement, development, and retention of women employees through several ERGs (employee resource groups), the BWN (Biocon Women's Network), the launch of our WLDP (Women Leadership Development Program), our DE&I mandatory programs, our POSH coaching across the company, and so much more. Receiving the award for Biocon Biologics were Chella Pandian Pitchai - Global Head, DE&I, Culture & Values, Talent, Sustainability, and Dr.Vidhya Sundararaman - Associate Scientific Manager, and the lead of our BWN in Chennai. Learn more about working with us: https://lnkd.in/gQ2T_wdZ
-
-
Ethics and Compliance are an intrinsic part of our work culture and has been fundamental to building trust with our patients, customers, partners, and communities that we serve. On this International Anti-Corruption week, our CEO & Managing Director, Shreehas Tambe underlines our steadfast dedication to upholding the highest ethical standards. "Respect, Honest and Integrity are core to our ways of working and fundamental to building confidence and trust with patients, customers, partners, and communities that we serve. As we celebrate International Anti-Corruption Day on December 9, 2024, I reaffirm our unwavering commitment to maintain the highest standards of ethical behaviour in all our interactions.” #InternationalAntiCorruptionDay #IntegrityMatters #Transparency #Accountability
-